oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
TLV:s betalningsvilja för nya läkemedel har analyserats: Kostnadseffektivitet och sjukdomens svårighetsgrad avgörande för subvention - Cancerläkemedel får kosta mer
Örebro University, Örebro University School of Business. Sahlgrenska akademin, Göteborgs Universitet, Sweden.ORCID iD: 0000-0003-1113-7478
Socialstyrelsen, Stockholm, Sweden.
2016 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 113, no 28-30Article in journal (Refereed) Published
Abstract [en]

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) is the government body responsible for deciding whether outpatient drugs are to be included in the pharmaceutical benefits scheme. This paper analyzed all decisions made by TLV between 2005 and 2011 in order to investigate how the cost-effectiveness of a drug and the severity of the disease the drug targets affected the likelihood of subsidy of a drug. We find that TLV places significant weight on both the costeffectiveness, measured as the cost per Quality-Adjusted Life Year (QALY), and disease severity. We also find that the higher cost per QALY approved for severe diseases is mainly represented by cancer drugs. Drugs targeting severe diseases other than cancer have a similar cost per QALY as for non-severe diseases.

Place, publisher, year, edition, pages
Swedish Medical Association , 2016. Vol. 113, no 28-30
National Category
Economics
Identifiers
URN: urn:nbn:se:oru:diva-62606Scopus ID: 2-s2.0-84978886303OAI: oai:DiVA.org:oru-62606DiVA: diva2:1157587
Available from: 2017-11-16 Created: 2017-11-16 Last updated: 2017-11-20Bibliographically approved

Open Access in DiVA

No full text

Scopus

Authority records BETA

Svensson, Mikael

Search in DiVA

By author/editor
Svensson, Mikael
By organisation
Örebro University School of Business
In the same journal
Läkartidningen
Economics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 19 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf